RHY

0.00%

7.6¢ rhythm biosciences limited

Rhy: Proxy forms., page-31

First 31 Last

Share
Profile

Follow
ShmoShady

556 Posts.

80

15/05/24

13:18

Post #: 73835527
Share

Originally posted by mega1981: ↑

For someone who holds no shares, you definately have a passion for a stock you do not hold or intend to buy!!

The decision by the Board to outsource the future design and development to a US based CMO, is an excellent decision by the Board as outlined in Market update in Dec 23. Clearly the Board has untaken a detailed lengthly review to arrive at this decision since the former CEO's departure. I as a shareholder, would much rather have a Board, who takes it time to look at all options and engages, appropriate external and internal advisers, as it is allowed to do under Sec 188 and Sec 189 of the Corps Act, which I am sure this Board would have done or should have done.

Re CEO search, clearly could not be commenced until the strategic review had been completed and as such the Board has indicated again in its market update in Dec 23 and Nov 23, that is continuing its search. That the fact that use LinkedIn as one of the tools for this search should not be an issue and the appointment of a head hunter, given the extortinate fees, is not to be taken lightly given the past CEO and from my contacts in the industry, this has already commenced. I suppose you would have an issue with word of mouth referrals as well!! Some of the best CEO's I have worked with have not come via the Head Hunter trough but via word of mouth.

The fact that you indicate that the CEO search was the trigger for the 249D, indicates that the Board has not bowed to threats or black mail by the requisitioning shareholders, so hats off to them for not putting up with this bully behaviour and taking the time to get it right. So until EGM and the dust settles, no CEO worth their salt would want to be involved, so well done Hall and Co for also inflicting your own special damage to RHY or do they fancy themselves as white knights on chargers!

Expand

That bag must be realllllll heavy now.

RHY Price at posting: 7.5¢ Sentiment: Sell Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BUX

Buxton projects new graphite province discovery at WA Narryer play

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

There are more pages in this discussion • 1 more message in this thread...

First 31 Last

Add RHY (ASX) to my watchlist

(20min delay)
Last 7.6¢		Change 0.000(0.00%)		Mkt cap ! $18.89M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
1	215025	7.6¢

Sellers (Offers)

Price($)	Vol.	No.
8.0¢	13055	2

View Market Depth

No.	Vol.	Price($)
1	1439	0.066
1	17000	0.065
2	40000	0.063
1	17085	0.062
1	5000	0.061

Price($)	Vol.	No.
0.080	13055	2
0.083	7260	1
0.084	43251	2
0.085	17407	1
0.091	161352	1

Last trade - 16.12pm 04/10/2024 (20 minute delay)

RHY (ASX) Chart

Day chart unavailable

Rhy: Proxy forms., page-31

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BCI reaches close of funding facility for salt-first part of Mardie project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Buxton projects new graphite province discovery at WA Narryer play

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Rhy: Proxy forms., page-31

Top Stories

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BCI reaches close of funding facility for salt-first part of Mardie project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Buxton projects new graphite province discovery at WA Narryer play

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News